NCT05447208View on ClinicalTrials.gov

Effect of GH on the Blastocyst Euploid Rate in AMA Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

March 1, 2026

Study Completion Date

December 31, 2026

Conditions
Preimplantation Genetic TestingGrowth HormoneAge, Parental
Interventions
DRUG

Growth Hormone

Growth hormone is supplemented before and during the ovarian stimulation till the day of oocyte retrieval

DRUG

GnRH antagonist

GnRH antagonist (Cetrorelix 0.25mg) once subcutaneously daily from day 6 of ovarian stimulation till the day of the ovulation trigger

Trial Locations (1)

200011

RECRUITING

Shanghai JIAI Genetics and IVF Institute, Shanghai

All Listed Sponsors
lead

ShangHai Ji Ai Genetics & IVF Institute

OTHER